Results From the 2020 Canadian Rheumatology Association's Workforce and Wellness Survey

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.

CEHB has an Arthritis Society Stars Career Development Award, funded by the Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis (STAR-19-0611/CIHR SI2-169745). JW receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). MH is supported by the Michael Smith Foundation for Health Research Scholar Awards in partnership with the Centre for Health Evaluation and Outcome Sciences (#16813). CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. S.C. Kulhawy-Wibe, MD, MSc, N.A. Johnson, MD, MSc, N.M.S. Hartfeld, MSc, MC, CCC, University of Calgary, Calgary, Alberta; J. Widdifield, PhD, Sunnybrook Research Institute, Holland Bone and Joint Program, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario; J.J.Y. Lee, MD, D. Jerome, MD, MEd, R. Shupak, MD, University of Toronto, Toronto, Ontario; J.C. Thorne, MD, University of Toronto, Toronto, and Centre of Arthritis Excellence, the Arthritis Program Research Group, Newmarket, Ontario; E.A. Yacyshyn, MD, Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; M. Batthish, MD, MSc, Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario; K. Jilkine, MD, Division of Rheumatology, Department of Medicine, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba; J. Purvis, MD, Department of Family Practice, Queen's University, Kingston, Ontario; J. Shamis, MD, North York General Hospital, Toronto, Ontario; J. Roberts, MD, Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; J. Kur, MD, University of British Columbia, Vancouver, British Columbia; J.E. Burt, BScPT, Rheumatology Services, Eastern Health, St. John's, Newfoundland; C. Barnabe, MD, MSc, C.E.H. Barber, MD, PhD, Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; M. Harrison, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Arthritis Research Canada, Vancouver, and Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia; J.E. Pope, MD, MPH, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr NW, HMRB Building, Room 451 Calgary, AB T2N 4N1, Canada. Email: cehbarbe@ucalgary.ca. Accepted for publication January 6, 2022.